Boston Health Group

Boston Health Group (BHG) is a leading healthcare service provider and hospital management organization that operates a network of specialized medical facilities, primarily in China. Founded in 2004, the group focuses on integrating international medical standards and advanced clinical technologies into the Chinese healthcare market, particularly in the fields of oncology, neurosurgery, and regenerative medicine. BHG's flagship institution, Beijing Puhua International Hospital, is globally recognized for providing sophisticated treatments such as stem cell therapies and robotic-assisted surgeries to a diverse patient base. The company has historically received significant backing from major global investment firms, including Morgan Stanley and Goldman Sachs, to expand its infrastructure and clinical capabilities across Asia.